Catherine Mary Woods

Title: Catherine Mary Woods: Innovator in Antibody Research

Introduction

Catherine Mary Woods is a prominent inventor based in La Jolla, CA (US). She has made significant contributions to the field of antibody research, holding a total of 3 patents. Her work focuses on developing innovative therapeutic solutions for various medical conditions.

Latest Patents

Catherine's latest patents include groundbreaking inventions such as anti-alpha2 integrin antibodies and their uses. This invention relates to humanized antibodies that bind to the I domain of alpha2 integrin, inhibiting its interaction with collagen. Additionally, she has developed therapeutic applications for these antibodies in treating alpha2beta1-mediated disorders. Another notable patent involves humanized antibodies specific for von Willebrand factor (vWF), which are designed to treat vWF mediated diseases or disorders.

Career Highlights

Catherine is currently associated with Glenmark Pharmaceuticals S.A., where she continues to advance her research in antibody development. Her innovative work has positioned her as a key figure in the pharmaceutical industry, contributing to the development of new therapeutic options.

Collaborations

Catherine collaborates with esteemed colleagues, including Elias Lazarides and Mark Bernard, to further enhance her research efforts and drive innovation in the field.

Conclusion

Catherine Mary Woods exemplifies the spirit of innovation in antibody research, with her patents paving the way for new treatments in medicine. Her contributions are invaluable to the scientific community and the advancement of healthcare solutions.